These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1518694)

  • 21. Neurodevelopmental and school performance of very low-birth-weight infants: a seven-year longitudinal study.
    Vohr BR; Garcia Coll CT
    Pediatrics; 1985 Sep; 76(3):345-50. PubMed ID: 2412199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the new definition of bronchopulmonary dysplasia more useful?
    Sahni R; Ammari A; Suri MS; Milisavljevic V; Ohira-Kist K; Wung JT; Polin RA
    J Perinatol; 2005 Jan; 25(1):41-6. PubMed ID: 15538399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
    Rosenberg AA; Kennaugh JM; Moreland SG; Fashaw LM; Hale KA; Torielli FM; Abman SH; Kinsella JP
    J Pediatr; 1997 Jul; 131(1 Pt 1):70-5. PubMed ID: 9255194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
    Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
    J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review.
    Beligere N; Rao R
    J Perinatol; 2008 Dec; 28 Suppl 3():S93-101. PubMed ID: 19057618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of mechanical ventilation for clinical management of persistent pulmonary hypertension of the newborn.
    Duara S; Gewitz MH; Fox WW
    Clin Perinatol; 1984 Oct; 11(3):641-52. PubMed ID: 6435924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.
    Gupta A; Rastogi S; Sahni R; Bhutada A; Bateman D; Rastogi D; Smerling A; Wung JT
    J Perinatol; 2002 Sep; 22(6):435-41. PubMed ID: 12168118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late neurodevelopmental outcome after repair of total anomalous pulmonary venous connection.
    Kirshbom PM; Flynn TB; Clancy RR; Ittenbach RF; Hartman DM; Paridon SM; Wernovsky G; Spray TL; Gaynor JW
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1091-7. PubMed ID: 15867785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure.
    Sills JH; Cvetnic WG; Pietz J
    J Perinatol; 1989 Mar; 9(1):43-8. PubMed ID: 2651595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe peripartum acidosis of the mature newborn infant (umbilical artery pH less than or equal to 7.00)--early morbidity and early growth].
    Rosegger H; Rosanelli K; Kratky M
    Klin Padiatr; 1984; 196(5):281-6. PubMed ID: 6436575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of neurodevelopmental outcome following bronchopulmonary dysplasia.
    Luchi JM; Bennett FC; Jackson JC
    Am J Dis Child; 1991 Jul; 145(7):813-7. PubMed ID: 1711774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow-up.
    Reyes Baez G; Gonzalez AR; Gomez Raspaldo G; Blasini I; Rivera CE
    P R Health Sci J; 2004 Mar; 23(1):9-12. PubMed ID: 15125213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ; Anbar RD; Mettelman BB
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary hypertension and the asphyxiated newborn.
    Lapointe A; Barrington KJ
    J Pediatr; 2011 Feb; 158(2 Suppl):e19-24. PubMed ID: 21238701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn.
    Walton JP; Hendricks-Munoz K
    J Speech Hear Res; 1991 Dec; 34(6):1362-70. PubMed ID: 1787718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy.
    Hosono S; Ohno T; Kimoto H; Shimizu M; Takahashi S; Harada K
    Pediatr Int; 2009 Feb; 51(1):79-83. PubMed ID: 19371283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuro-psychological development of a group of children with neonatal respiratory distress treated with intermittent positive-pressure respirator].
    Cukier F; Amiel-Tison C; Minkowski A
    Arch Fr Pediatr; 1976 Feb; 33(2):131-42. PubMed ID: 788669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostacyclin treatment for persistent pulmonary hypertension of the newborn.
    Eronen M; Pohjavuori M; Andersson S; Pesonen E; Raivio KO
    Pediatr Cardiol; 1997; 18(1):3-7. PubMed ID: 8960484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.